Clinical Trial

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This Study of ABBV-295 subcutaneous injections will assess pharmacokinetics and adverse events in healthy adult women participants with overweight or obesity taking oral contraceptives.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-28
Trial Details
NCT Number NCT07414784
Lead Sponsor AbbVie
Conditions Healthy Volunteer
Enrollment 20 participants
Start Date 2026-02-11
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-27